Business Event Theme Industry Type of Content Type of Source

Contify classifies all the content under various themes, which essentially indicate what type of activity or development is the story about. Contify's strong editorial team has identified business, economy and general activities topics with which most news and other information can be identified. Browse the following list, or click on any theme to view related stories.

Name
Description
  • Automobiles Stories related to the design, production, marketing, and sale of motor vehicles. Includes developments in car technology, industry trends, and market dynamics.
    • EV Charging Stories concerning the infrastructure and technology related to charging electric vehicles. Includes developments in charging stations, networks, and innovations in charging speeds.
    • EV Batteries Stories about batteries used in electric vehicles, focusing on advancements in battery technology, manufacturing, capacity, and charging efficiency.
  • Banking and Financial Services Stories about banks and financial institutions that accept deposits, offer credit, and provide other financial services. Encompasses regulatory changes, technological advancements, and market strategies in banking.
    • Cryptocurrency Stories related to decentralized digital currencies and blockchain-based tokens. Includes the creation, trading, regulation, and adoption of cryptocurrencies and innovations in crypto platforms and technologies.
    • Digital Lending/ BNPL Stories related to online lending platforms and "Buy Now, Pay Later" services. Includes fintech innovations in lending, consumer credit trends, and regulatory considerations.
    • Digital Payments Stories about electronic payment systems and platforms that enable digital transactions. Includes mobile wallets, online payment services, and advancements in payment security.
  • Conferences/Events Stories related to industry conferences, seminars, business summits, and exhibitions. Includes announcements of events, company participation, and key takeaways from such gatherings.
  • Containers & Packaging Stories about the design, production, and innovation in containers and packaging solutions across industries. Includes sustainable packaging and material advancements.
    • Biodegradable/ Green Packaging Stories focused on environmentally friendly packaging options that are biodegradable or recyclable. Includes innovations in sustainable materials and industry adoption.
  • Energy Stories related to the production, distribution, and consumption of energy from various sources. Includes developments in traditional and renewable energy sectors, policy changes, and market trends.
    • Energy Transition Stories concerning the shift from fossil fuels to renewable energy sources. Includes policy changes, investment in renewables, and strategies for reducing carbon emissions.
    • Energy Efficiency Stories about methods and technologies that reduce energy consumption and enhance efficiency. Includes energy-saving innovations, regulations, and corporate initiatives.
    • PPAs (Power Purchase Agreements ) Stories about contracts between electricity producers and buyers. Includes agreements for renewable energy projects and long-term energy procurement strategies.
  • ESG & Sustainability Stories related to Environmental, Social, and Governance criteria in business practices. Includes corporate sustainability efforts, ethical governance, and social responsibility initiatives.
    • CSR/Sustainability Stories related to Corporate Social Responsibility and sustainability efforts by organizations. Encompasses ethical business practices, environmental initiatives, and social impact programs.
    • Decarbonisation Stories about efforts to reduce carbon dioxide emissions across industries. Includes technological innovations, policy measures, and corporate strategies for lowering carbon footprints.
    • Carbon Offset Stories about activities that compensate for carbon dioxide emissions. Includes carbon credits, offset projects, and corporate strategies for achieving carbon neutrality.
    • Diversity, Equity, and Inclusion Stories focusing on initiatives and policies promoting diversity, equity, and inclusion within organizations. Includes workplace diversity efforts and inclusive business practices.
    • Waste Management Stories about the collection, transportation, processing, and disposal of waste materials. Includes recycling initiatives and sustainable waste solutions.
  • Financial/ Capital Market Stories about activities in financial markets, including trading, investment strategies, market trends, and regulatory developments.
    • Fintech Stories about financial technology companies and innovations disrupting traditional financial services. Includes digital banking, payment systems, and online investment platforms.
    • CBDC Stories concerning Central Bank Digital Currencies issued by central banks. Includes discussions on implementation, monetary policy implications, and technological aspects.
  • Food Stories related to the production, processing, distribution, and retail of food products. Includes agricultural developments, food industry trends, and regulatory issues.
    • Food Safety Stories concerning the handling, preparation, and storage of food to prevent illness. Includes regulations, food recalls, and industry standards for safety.
    • Ingredient Regulations Stories about legal and regulatory standards for food ingredients. Includes approvals, bans, and labeling requirements for additives and substances in food products.
    • Plant Protein Stories about proteins derived from plant sources used as alternatives to animal proteins. Includes developments in plant-based foods and the market for vegetarian and vegan products.
    • Food Preservation Stories about methods and technologies used to preserve food quality and extend shelf life. Includes packaging innovations, refrigeration, and preservation techniques.
    • Organic Farming Stories related to agricultural practices that use natural inputs and avoid synthetic chemicals. Includes organic certification, farming methods, and market trends.
  • Healthcare Stories about medical services, health care providers, medical research, and health policy. Includes advancements in treatments, health care technology, and industry developments.
    • Conditional Approval/Accelerated Approval Stories regarding drugs receiving expedited approval based on surrogate endpoints. Includes implications for patient access and further research requirements.
    • NDA Submission/Approval Stories related to the comprehensive processes and milestones required for product validation and market authorization in the healthcare sector. Includes major regulatory pathways (NDA, ANDA, BLA, sBLA, 510(k), De Novo, etc.), compliance strategies, timelines, risk assessments, and collaborations with regulatory authorities to ensure that health products and medical innovations meet safety, efficacy, and quality standards.
    • IDSMC/Independent Review Stories about Independent Data Safety Monitoring Committees reviewing clinical trial data. Includes findings and recommendations.
    • sBLA Submission/Approval Stories about supplemental Biologics License Applications submitted for changes to an approved biologic product. Includes submissions and approval decisions.
    • RTOR Pilot Program Stories about the Real-Time Oncology Review program aimed at expediting oncology drug approvals. Includes program participation and outcomes.
    • Complete Response Letters Stories about regulatory agencies issuing letters requiring additional information before approving a drug. Includes company responses and next steps.
    • IND Submission/Approval Stories about Investigational New Drug applications submitted to regulatory agencies to begin clinical trials. Includes submission announcements and approvals.
    • Orphan Drug Designation Stories concerning drugs designated for treating rare diseases. Includes benefits of the designation and impact on drug development.
    • Breakthrough Therapy Designation Stories about therapies designated by regulatory agencies as breakthroughs due to their potential to treat serious conditions. Includes announcements of designations and their implications.
    • BLA Submission/Approval Stories about Biologics License Applications submitted for the approval of biological products. Includes regulatory submissions and approvals in the biologics field.
    • Expanded Access Program/Compassionate Stories about programs allowing patients access to investigational drugs outside clinical trials. Includes policy changes and program announcements.
    • ANDA Submission/Approval Stories concerning Abbreviated New Drug Applications submitted to regulatory agencies for generic drug approval. Includes submission announcements and approval updates.
    • Regulatory Submissions & Approvals Stories related to the regulatory processes and approvals required for product validation and market authorization in the healthcare sector. Includes major regulatory pathways (NDA, ANDA, BLA, sBLA, 510(k), De Novo, etc.), compliance strategies, timelines, risk assessments, and collaborations with regulatory authorities to ensure that health products and medical innovations meet safety, efficacy, and quality standard.
    • MDR/IVDR Regulation Stories related to the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) in the EU. Includes compliance efforts and regulatory updates.
    • Medical Robotics Stories about robotic systems used in medical procedures and surgeries. Includes technological advancements and adoption in health care facilities.
    • PRIME Designation Stories about the PRIority MEdicines scheme in the EU that supports medicines with significant potential. Includes designation announcements and development support.
    • Clinical Trial Results Stories reporting outcomes from clinical trials. Includes efficacy, safety data, and implications for drug development.
    • Digital Health Stories about the use of technology to improve health care delivery. Includes telemedicine, health apps, wearable devices, and electronic health records.
    • PDUFA date Stories regarding the Prescription Drug User Fee Act dates, which are target dates for the FDA to make approval decisions. Includes expectations and outcomes.
    • Fast Track Designation Stories concerning drugs that receive Fast Track status for expedited development and review. Includes benefits and implications of the designation.
    • Contract Manufacturing Stories about companies providing manufacturing services on a contract basis. Includes partnerships, capacity expansions, and industry trends.
    • Drug Safety Stories about the safety profiles of drugs, including adverse effects and safety warnings. Includes regulatory actions and company responses.
    • CHMP Opinion Stories concerning the Committee for Medicinal Products for Human Use (CHMP) opinions on medicinal products. Includes recommendations for approval or rejection in the EU.
    • Companion Diagnostics Stories about diagnostic tests used to determine the suitability of a patient for a particular therapy. Includes development and approval of such diagnostics.
    • Patient Dosing Stories about the administration of drugs to patients in clinical trials. Includes dosing milestones and safety observations.
    • Clinical Trial Suspensions Stories about the suspension of clinical trials. Includes reasons for suspension and potential impacts on drug development.
    • Clinical Trial Progress Updates Stories related to updates on clinical trials and their progress. Includes regulatory approvals, participant recruitment, and key milestones aimed at evaluating the safety and effectiveness of medical interventions.
    • Cell and Gene Therapy Stories about medical treatments that modify cells or genes to treat diseases. Includes clinical trials, approvals, and technological advancements in this field.
    • Pre-clinical Stories about research conducted before clinical trials, including laboratory and animal studies. Includes findings that support further drug development.
    • Drug and Market Exclusivity Stories related to periods during which a drug company has exclusive rights to market a drug. Includes patent discussions and regulatory exclusivity periods.
    • RMAT (Regenerative Medicine Advanced Therapy) Designation Stories about therapies that receive RMAT designation for expedited development and review. Includes benefits and qualifying criteria.
    • De Novo Approval Stories concerning the De Novo pathway for novel medical devices with low to moderate risk. Includes submissions and approvals through this regulatory route.
    • Cannabidiol (CBD) Stories related to CBD, a non-psychoactive compound found in cannabis plants. Includes discussions on medical uses, regulatory status, and market trends in CBD products.
    • Expedited Review Designations Stories related to the regulatory strategies and pathways designed to speed the development, review, and oversight of highly promising or urgently needed medical products. Includes IDSMC/Independent Review, Priority Review, Fast Track Designation, PRIME (Priority Medicines) Designation, RMAT (Regenerative Medicine Advanced Therapy) Designation, and Rare Pediatric Disease (RPDD) Designation, all of which enable accelerated timelines, enhanced collaboration with regulatory authorities, and vigilant safety assessments to bring critical healthcare innovations to patients more swiftly.
    • RPDD (Rare Pediatric Disease) Designation Stories concerning drugs designated for treating rare pediatric diseases. Includes potential incentives like priority review vouchers.
    • Clinical Trial Terminations Stories concerning the termination of clinical trials before completion. Includes causes and implications for stakeholders.
    • Pricing and Reimbursement Stories about the pricing of drugs and medical services, including reimbursement policies from insurers and government programs.
    • Clinical Trial Initiations Stories announcing the initiation of clinical trials. Includes information on the study phase, targets, and objectives.
  • Insurance Stories about the insurance industry, including policy offerings, regulatory changes, and market developments. Includes health, life, property, and casualty insurance sectors.
    • InsurTech/ Digital Insurance Stories about technology-driven innovations in the insurance industry. Includes digital platforms, online policy management, and AI applications in insurance.
  • Retail Stories related to the sale of goods to consumers through various channels. Includes brick-and-mortar stores, e-commerce, and consumer trends.
    • DTC (Direct-to-consumer) Stories about companies selling products directly to consumers, bypassing traditional retail channels. Includes online sales models and marketing strategies.
  • Technology Stories about advancements and trends in technology across industries. Includes innovation in software, hardware, and tech services.
    • Blockchain Stories about distributed ledger technology used for secure and transparent transactions. Includes applications beyond cryptocurrency, such as supply chain and smart contracts.
    • AR/VR Stories related to Augmented Reality and Virtual Reality technologies. Includes applications in gaming, education, training, and enterprise solutions.
    • Advanced Manufacturing Stories concerning innovative manufacturing processes that improve products and efficiency. Includes automation, 3D printing, and smart factories.
    • AI/ML Stories about the development and application of AI technologies. Includes machine learning, neural networks, and AI-driven solutions in various sectors.
    • Drones Stories about unmanned aerial vehicles used in various applications. Includes commercial drone use, regulations, and technological advancements.
    • Data & Analytics Stories about the collection, analysis, and utilization of data to inform decisions. Includes big data, data science, and analytics tools.
    • Internet of Things (IoT) Stories concerning interconnected devices that collect and exchange data. Includes applications in smart homes, industries, and urban infrastructure.
    • Simulations/ Testing/ Maintenance Stories about using simulations and testing in product development and maintenance processes. Includes virtual testing environments and predictive maintenance.
    • Cybersecurity Stories concerning the protection of systems, networks, and data from digital attacks. Includes security breaches, cybersecurity solutions, and policy developments.
    • Datacenter and Cloud Services Stories related to the provision of data storage and processing services. Includes cloud computing, data center infrastructure, and service providers.
  • Transportation Stories related to the movement of people and goods. Includes developments in public transit, logistics, and transportation infrastructure.
    • E-mobility/ Electrification Stories concerning electric mobility solutions and innovative transportation models. Includes electric bikes, scooters, ride-sharing, and mobility-as-a-service.
    • Autonomous Vehicles Stories about self-driving vehicles equipped with technology to navigate without human input. Includes advancements in autonomy levels, regulations, and industry players.
  • Utilities Stories related to companies providing essential public services like electricity, gas, and water. Includes infrastructure developments and regulatory issues.
  • Warehouse/Storage Stories related to the management and optimization of physical storage facilities and inventory. Includes warehousing best practices, distribution logistics, and solutions that support efficient supply chain operations.
    • Warehouse Management Stories about the operations and technologies used in managing warehouse activities. Includes inventory management systems and efficiency improvements.
    • Warehouse Robotics Stories about the use of robots in warehouse operations. Includes automation of picking, packing, and material handling processes.